Cytokeratin 5 Antikörper
Kurzübersicht für Cytokeratin 5 Antikörper (ABIN285685)
Target
Alle Cytokeratin 5 (KRT5) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Reinheit
- Stabilized antiserum
-
Immunogen
- Cytokeratin 5 antibody was raised in guinea pig using recombinant human keratin K5 as the immunogen.
-
-
-
-
Applikationshinweise
- IHC-F: 1:100, IHC-P: 1:50, WB: 1:5,000-1:10,000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Suppleid as a liquid with 0.09 % NaN3 and 0.5 % BSA.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4 °C
-
-
-
Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4." in: Nature communications, Vol. 10, Issue 1, pp. 5546, (2020) (PubMed).
: "p73 regulates epidermal wound healing and induced keratinocyte programming." in: PLoS ONE, Vol. 14, Issue 6, pp. e0218458, (2019) (PubMed).
: "
-
Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4." in: Nature communications, Vol. 10, Issue 1, pp. 5546, (2020) (PubMed).
-
- Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
-
Andere Bezeichnung
- Cytokeratin 5
Target
-